跳至主要内容
临床试验/CTRI/2019/10/021548
CTRI/2019/10/021548已完成未知

orfloxacin Prophylaxis for prevention of bacterial infections in Acute On Chronic Liver Failure Patients- A Placebo-Controlled Randomized Trial. - NPPSA

A0 个研究点目标入组 143 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
A
入组人数
143

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • ACLF patients aged between 18-75 years, either admitted or attending the out-patient department will be recruited for the study.

排除标准

  • 1. Patients with sepsis â?? fever, positive blood, and urine cultures, procalcitonin >2, Allergy to fluoroquinolones.
  • 2.Patients in the intensive care unit
  • 3.Renal failure (S. Creatinine >2.5mg%)
  • 4.Pregnancy
  • 5.Patients with a history of Spontaneous bacterial peritonitis
  • 6.Patients with shock requiring vasopressor support
  • 7.Patients with malignancy
  • 8.Recent Gastrointestinal bleeding ( <7 days)
  • 9.Patients with a history of Hepatic encephalopathy and /or on Rifaximin therapy
  • 10.Patients who received fluoroquinolones in last one month
  • 11.Patients on intravenous antibiotics
  • 12.Refusal to participate

研究者

发起方
A

相似试验